Citations 32
Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Faderl, Stefan, Pagel, John M. , Yoon, Sung‐Soo, Pardanani, Animesh , Hauptschein, Robert, Lee, Kyoung-June, Cortes, Jörge E. , Jung, Chul Won , Yoon, Sung‐Soo , Koh, Youngil , Lee, Je‐Hwan
Journal of Clinical Oncology | April 19, 2019 | Volume: 33 | Issue: 15_suppl | Pages: 7044-7044
A randomized open label exploratory controlled trial of CLT-008 myeloid progenitor cells (MPC) to decrease infections during induction for AML.
Abboud, Camille N. , Akard, Luke P., Foran, James M. , Frankfurt, Olga, Hsu, Jack W., Lister, John , Pagel, John M. , Schiller, Gary J. , Solh, Melham, Üstün, Celalettin , Wieduwilt, Matthew J. , Janice, Brown, Wong, Alicia , Kellerman, Lois, Syoc, Rodney Van, Mamelok, Rick, Andreadis, Charalambos Babis , Desai, Pinkal , Gill, Saar , Syoc, Rod Van, Ravandi, Farhad
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 7043-7043